| 1. |
Yanada M, Ota S, Mukae J, Nara M, Kako S, Nishikawa A, Uchida N, Sawa M, Nakano N, Onizuka M, Kanda Y, Ichinohe T, Atsuta Y, Yano S. Autologous hematopoietic cell transplantation during second or subsequent complete remission of acute promyelocytic leukemia: a prognostic factor analysis. Bone Marrow Transplant. 2022 Jan;57(1):78-82. doi: 10.1038/s41409-021-01501-9. Epub 2021 Oct 13. |
| 2. |
Kanda J, Hayashi H, Ruggeri A, Kimura F, Volt F, Takahashi S, Kako S, Tozatto-Maio K, Yanada M, Sanz G, Uchida N, Angelucci E, Kato S, Mohty M, Forcade E, Tanaka M, Sierra J, Ohta T, Saccardi R, Fukuda T, Ichinohe T, Kimura T, Rocha V, Okamoto S, Nagler A, Atsuta Y, Gluckman E. The impact of GVHD on outcomes after adult single cord blood transplantation in European and Japanese populations. Bone Marrow Transplant. 2022 Jan;57(1):57-64. doi: 10.1038/s41409-021-01479-4. Epub 2021 Oct 11. |
| 3. |
Wakita S, Sakaguchi M, Oh I, Kako S, Toya T, Najima Y, Doki N, Kanda J, Kuroda J, Mori S, Satake A, Usuki K, Ueki T, Uoshima N, Kobayashi Y, Kawata E, Tajika K, Nagao Y, Shono K, Shibusawa M, Tadokoro J, Kayamori K, Hagihara M, Uchiyama H, Uchida N, Kubota Y, Kimura S, Nagoshi H, Ichinohe T, Kurosawa S, Motomura S, Hashimoto A, Muto H, Sato E, Ogata M, Mitsuhashi K, Ando J, Marumo A, Omori I, Fujiwara Y, Terada K, Yui S, Arai K, Kitano T, Miyata M, Kurosawa A, Mizoguchi A, Komatsu N, Fukuda T, Ohashi K, Kanda Y, Inokuchi K, Yamaguchi H. Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia. Blood Adv. 2022 Jan 11;6(11):238-247. doi: 10.1182/bloodadvances. 2021004292. |
| 4. |
Fukushima N, Mino T, Arihiro K, Ichinohe T. Cooccurrence of CD10-positive and CD10-negative mantle cell lymphoma complicated with central nervous system involvement solely by CD10-positive population. Cureus. 2022 Jan 17;14(1):e21341. doi: 10.7759/cureus. 21341. |
| 5. |
Kamachi K, Ureshino H, Watanabe T, Yoshida-Sakai N, Fukuda-Kurahashi Y, Kawasoe K, Hoshiko T, Yamamoto Y, Kurahashi Y, Kimura S. Combination of a new oral demethylating agent, OR2100, and venetoclax for treatment of acute myeloid leukemia. Cancer Res Commun. 2023 Feb 21;3(2):297-308. doi: 10.1158/2767-9764.CRC-22-0259. |
| 6. |
Fuchida SI, Kawamura K, Sunami K, Tsukada N, Fujii S, Ohkawara H, Usuki K, Wake A, Endo S, Ishiyama K, Ueda Y, Nakamura Y, Miyamoto T, Fukuda T, Ichinohe T, Atsuta Y, Takamatsu H. Retrospective Analysis of Autologous Stem Cell Transplantation for AL Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation. Transplant Cell Ther. 2022 Feb;28(2):76-82. doi: 10.1016/j.jtct.2021.10.021. Epub 2021 Nov 11. |
| 7. |
Nishi H, Ohta K, Kuramoto Y, Shigeishi H, Obayashi T, Yoshioka Y, Konishi M, Munenaga S, Nagoshi H, Yoshida T, Fukushima N, Kakimoto N, Ohge H, Kurihara H, Ichinohe T, Kawaguchi H. Periodontal inflamed surface area in oral cavity associated with febrile neutropenia in patients with hematologic malignancy undergoing chemotherapy. Sci Rep. 2022 Feb 15;12(1):2483. doi: 10.1038/s41598-022-06485-0. |
| 8. |
Utsunomiya A, Tokunaga M, Nakano N, Fujiwara H, Miyamoto T, Ogata M, Miyazaki Y, Ishitsuka K, Sakaida E, Taji H, Wakayama T, Ichinohe T, Fukuda T, Atsuta Y, Kato K, Yoshimitsu M. Long-term follow-up of patients with ATL after autologous stem cell transplantation. Bone Marrow Transplant. 2022 Feb;57(2):323-325. doi: 10.1038/s41409-021-01412-9. Epub 2022 Jan 23. |
| 9. |
Kuno M, Yamasaki S, Fujii N, Ishida Y, Fukuda T, Kataoka K, Uchida N, Katayama Y, Sato M, Onai D, Miyamoto T, Ota S, Yoshioka S, Ara T, Hangaishi A, Hashii Y, Onizuka M, Ichinohe T, Atsuta Y, Inamoto Y; on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group. Characterization of myeloid neoplasms following allogeneic hematopoietic cell transplantation. Am J Hematol. 2022 Feb 1;97(2):185-193. doi: 10.1002/ajh.26401. Epub 2021 Nov 16. |
| 10. |
Imahashi N, Terakura S, Kondo E, Kato K, Kim SW, Shinohara A, Watanabe M, Fukuda T, Uchida N, Kobayashi H, Ishikawa J, Kataoka K, Shiratori S, Ikeda T, Matsuoka KI, Yoshida S, Kondo T, Kimura T, Onizuka M, Ichinohe T, Atsuta Y, Kanda J. Impact of donor types on reduced-intensity conditioning allogeneic stem cell transplant for mature lymphoid malignancies. Bone Marrow Transplant. 2022 Feb;57(2):243-251. doi: 10.1038/s41409-021-01525-1. Epub 2021 Nov 24. |
| 11. |
Iwasaki M, Kanda J, Tanaka H, Shindo T, Sato T, Doki N, Fukuda T, Ozawa Y, Eto T, Uchida N, Katayama Y, Kataoka K, Ara T, Ota S, Onizuka M, Kanda Y, Ichinohe T, Atsuta Y, Morishima S. Impact of HLA epitope matching on outcomes after unrelated bone marrow transplantation. Front Immunol 2022 Mar 3;13:811733. doi: 10.3389/fimmu.2022.811733. |
| 12. |
Kawajiri A, Kawase T, Tanaka H, Fukuda T, Mukae J, Ozawa Y, Eto T, Uchida N, Mori T, Ashida T, Kondo T, Onizuka M, Ichinohe T, Atsuta Y, Morishima S, Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Human leukocyte antigen (HLA) haplotype matching in unrelated single HLA allele mismatch bone marrow transplantation. Bone Marrow Transplant. 2022 Mar;57(3):407-415. doi: 10.1038/s41409-021-01552-y. Epub 2022 Jan 21. |
| 13. |
Wada F, Watanabe M, Konuma T, Okabe M, Kobayashi S, Uchida N, Ikegame K, Tanaka M, Sugio Y, Mukae J, Onizuka M, Kawakita T, Kuriyama T, Takahashi S, Fukuda T, Nakano N, Sawa M, Kimura T, Ichinohe T, Atsuta Y, Kanda J. Donor/Source Working Group of the Japan Society for Hematopoietic Cell Transplantation. HLA 1-3 antigen-mismatched related peripheral blood stem cells transplantation using low-dose antithymocyte globulin versus unrelated cord blood transplantation. Am J Hematol. 2022 Mar 1;97(3):311-321. doi: 10.1002/ajh.26446. Epub 2022 Jan 3. |
| 14. |
Kako S, Hayakawa F, Miyamura K, Tanaka J, Imai K, Kanda J, Morishima S, Uchida N, Doki N, Ikegame K, Ozawa Y, Takada S, Usui N, Ohtake S, Kiyoi H, Matsumura I, Miyazaki Y, Ichinohe T, Fukuda T, Atsuta Y, Kanda Y. Decision analysis for unrelated bone marrow transplantation or immediate cord blood transplantation for patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission. Transplant Cell Ther. 2022 Mar;28(3):161.e1-161.e10. doi: 10.1016/j.jtct.2021.11.021. Epub 2021 Dec 4. |
| 15. |
Harada K, Mizuno S, Yano S, Takami A, Ishii H, Ikegame K, Najima Y, Kako S, Ashida T, Shiratori S, Ota S, Onizuka M, Fukushima K, Fukuda T, Ichinohe T, Atsuta Y, Yanada M. Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia. Ann Hematol. 2022 Mar;101(3):643-653. doi: 10.1007/s00277-021-04731-5. EPub 2022 Jan 6. |
| 16. |
Tanahashi H, Yamaguchi K, Koura T, Kambara T, Yamada K, Sakamoto S, Horimasu Y, Masuda T, Miyamoto S, Nakashima T, Iwamoto H, Fukushima N, Fujitaka K, Hamada H, Ichinohe T, Ohshima K, Hattori N. Primary Pulmonary Mucosa-associated Lymphoid Tissue Lymphoma with the High Expression of IgG4: A Case Report. Intern Med. 2022 Apr 1;61(7):1043-1048. doi: 10.2169/internalmedicine.7436-21. Epub 2021 Sep 18. |
| 17. |
Yoshida-Sakai N, Watanabe T, Yamamoto Y, Ureshino H, Kamachi K, Kurahashi Y, Fukuda-Kurahashi Y, Kimura S. Adult T-cell leukemia-lymphoma acquires resistance to DNA demethylating agents through dysregulation of enzymes involved in pyrimidine metabolism. Int J Cancer. 2022 Apr 1;150(7):1184-1197. |
| 18. |
Konuma T, Mizuno S, Kondo T, Arai Y, Uchida N, Takahashi S, Tanaka M, Kuriyama T, Miyakoshi S, Onizuka M, Ota S, Sugio Y, Kouzai Y, Kawakita T, Kobayashi H, Ozawa Y, Kimura T, Ichinohe T, Atsuta Y, Yanada M; Adult Acute Myeloid Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy. Improved trends in survival and engraftment after single cord blood transplantation for adult acute myeloid leukemia. Blood Cancer J. 2022 May 25;12(5):81. doi: 10.1038/s41408-022-00678-6. |
| 19. |
Sekiya T, Kasahara H, Takemura R, Fujita S, Kato J, Doki N, Katayama Y, Ozawa Y, Takada S, Eto T, Fukuda T, Ichinohe T, Takanashi M, Onizuka M, Atsuta Y, Okamoto S, Yoshimura A, Takaki S, Mori T. Essential Roles of the Transcription Factor NR4A1 in Regulatory T Cell Differentiation under the Influence of Immunosuppressants. J Immunol. 2022 May 1;208(9):2122-2130. doi: 10.4049/jimmunol.2100808. Epub 2022 Apr 6. |
| 20. |
Kameda K, Kako S, Kim SW, Usui Y, Kato K, Fukuda T, Uchida N, Kobayashi H, Wakayama T, Sakaida E, Yano S, Imada K, Nara M, Ikeda T, Fuchida S, Ishikawa J, Sugahara H, Kanda J, Kimura T, Ichinohe T, Atsuta Y, Kondo E. Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITL. Leukemia. 2022 May;36(5):1361-1370. doi: 10.1038/s41375-022-01545-w. Epub 2022 Mar 28. |
| 21. |
Sugihara A, Katsuya H, Ureshino H, Kido S, Kimura S. Alveolar rhabdomyosarcoma with massive bone marrow infiltration and disseminated intravascular coagulation mimicking acute leukemia. EJHaem. 2022 May 18;3(3):1062-1063. |
| 22. |
Shimada H, Tanizawa A, Kondo T, Nagamura-Inoue T, Yasui M, Tojo A, Muramatsu H, Eto T, Doki N, Tanaka M, Sato M, Noguchi M, Uchida N, Takahashi Y, Sakata N, Ichinohe T, Hashii Y, Kato K, Atsuta Y, Ohashi K; Pediatric and Adult CML/MPN Working Groups of the Japanese Society for Transplantation and Cellular Therapy. Prognostic factors for outcomes of allogeneic HSCT for children and adolescents/young Adults with CML in the TKI era. Transplant Cell Ther. 2022 Jul;28(7):376-389. doi: 10.1016/j.jtct.2022.04.011. Epub 2022 Apr 18. |
| 23. |
Haratake D, Kanno K, Ichinohe T, Ito M. Case of non-secretory multiple myeloma eventually diagnosed by 18F-FDG PET/CT. Clin Case Rep. 2022 Jun 9;10(6):e05628. doi: 10.1002/ccr3.5628. |
| 24. |
Yamamoto M, Sato M, Onishi Y, Sasahara Y, Sano H, Masuko M, Nakamae H, Matsuoka KI, Ara T, Washio K, Onizuka M, Watanabe K, Takahashi Y, Hirakawa T, Nishio M, Sakashita C, Kobayashi T, Sawada A, Ichinohe T, Fukuda T, Hashii Y, Atsuta Y, Arai A. Registry data analysis of hematopoietic stem cell transplantation on systemic chronic active Epstein-Barr virus infection patients in Japan. Am J Hematol. 2022 Jun 1;97(6):780-790. doi: 10.1002/ajh.26544. Epub 2022 Mar 30. |
| 25. |
Yoshida-Sakai N, Oe K, Kimura Y, Ureshino H, Nomiyama K, Hashiguchi M, Jojima H, Imamura Y, Ohshima K, Okamura T. Coexistence of gastric and pulmonary MALT lymphoma and a clonally related, disseminated large B cell lymphoma with conspicuous angiotropism. Ann Hematol. 2022 Jun;101(6):1383-1385. |
| 26. |
Kanda J, Hirabayashi S, Yokoyama H, Kawase T, Tanaka H, Uchida N, Taniguchi S, Takahashi S, Onizuka M, Tanaka M, Sugio Y, Eto T, Kanda Y, Kimura T, Ichinohe T, Atsuta Y, Morishima S; Japanese Society for Transplantation and Cellular Therapy's HLA Working Group. Effect of Multiple HLA Locus Mismatches on Outcomes after Single Cord Blood Transplantation. Transplant Cell Ther. 2022 Jul;28(7):398.e1-398.e9. doi: 10.1016/j.jtct.2022.05.005. Epub 2022 May 13. |
| 27. |
Yokoyama H, Kanaya M, Iemura T, Hirayama M, Yamasaki S, Kondo T, Uchida N, Takahashi S, Tanaka M, Onizuka M, Ozawa Y, Kozai Y, Eto T, Sugio Y, Hamamura A, Kawakita T, Aotsuka N, Takada S, Wake A, Kimura T, Ichinohe T, Atsuta Y, Yanada M, Morishima S. Improved outcomes of single-unit cord blood transplantation for acute myeloid leukemia by killer immunoglobulin-like receptor 2DL1-ligand mismatch. Bone Marrow Transplant. 2022 Jul;57(7):1171-1179. doi: 10.1038/s41409-022-01700-y. Epub 2022 May 10. |
| 28. |
Nagaie T, Kamachi K, Kitamura H, Ureshino H, Akashi M, Nishimura K, Meiri H, Kimura S, Miyahara M. Eosinophilic cystitis mimicking hemorrhagic cystitis in relapsed follicular lymphoma. Int Cancer Conf J. 2022 Jul 21;11(4):298-301. |
| 29. |
Shimazu Y, Murata M, Kondo T, Minami Y, Tachibana T, Doki N, Uchida N, Ozawa Y, Yano S, Fukuda T, Kato J, Ara T, Eto T, Ishikawa J, Nakamae H, Tanaka J, Ichinohe T, Atsuta Y, Nagamura-Inoue T; working group of the Japan Society for Transplantation and Cellular Therapy. The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation Hematol Oncol. 2022 Aug;40(3):442-456. doi: 10.1002/hon.3000. Epub 2022 Apr 12. |
| 30. |
Harada K, Morita-Fujita M, Fukuda T, Ozawa Y, Doki N, Toyosaki M, Maruyama Y, Kanda Y, Ashida T, Eto T, Takada S, Uchida N, Ichinohe T, Kanda J, Onizuka M, Atsuta Y, Kako S, Arai Y. Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults. Cytotherapy. 2022 Sep;24(9):954-961. doi: 10.1016/j.jcyt.2022.03.004. Epub 2022 May 7. |
| 31. |
Jo T, Arai Y, Kondo T, Mizuno S, Hirabayashi S, Inamoto Y, Doki N, Fukuda T, Ozawa Y, Katayama Y, Kanda Y, Fukushima K, Matsuoka KI, Takada S, Sawa M, Ashida T, Onizuka M, Ichinohe T, Atsuta Y, Kanda J, Yanada M. Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients. Cytotherapy. 2022 Oct;24(10):1013-1025. doi: 10.1016/ j.jcyt.2022.05.009. Epub 2022 Jun 18. |
| 32. |
Itonaga H, Kida M, Doki N, Uchida N, Ozawa Y, Fukuda T, Ueda Y, Kataoka K, Katayama Y, Ota S, Matsuoka K, Kondo T, Eto T, Kanda J, Ichinohe T, Atsuta Y, Miyazaki Y, Ishiyama K. Outcome of therapy-related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysis. Hematol Oncol. 2022 Oct;40(4):752-762. doi: 10.1002/hon.2991. Epub 2022 Apr 5.* |
| 33. |
Ureshino H, Kamachi K, Shindo T, Kimura S. Favorable HLA Polymorphisms are Associated with Lower Molecular Relapse after Tyrosine Kinase Discontinuation in Patients with Chronic Myeloid Leukemia.Indian J Hematol Blood Transfus. 2022 Oct;38(4):760-761. |
| 34. |
Yoshikawa Y, Imamura M, Yamauchi M, Hayes CN, Aikata H, Okamoto W, Miyata Y, Okada M, Hattori N, Sugiyama K, Yoshioka Y, Toratani S, Takechi M, Ichinohe T, Ueda T, Takeno S, Kobayashi T, Ohdan H, Teishima J, Hide M, Nagata Y, Kudo Y, Iida K, Chayama K. Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors. BMC Cancer. 2022 Nov 29;22(1):1232. doi: 10.1186/s12885-022-10327-7. |
| 35. |
Ohira M, Kobayashi T, Tanaka Y, Imaoka Y, Sato K, Imaoka K, Nakano R, Doskali M, Piao J, Nakamura M, Yoshida T, Ichinohe T, Kawano R, Yoshimura K, Ueda K, Tamura N, Hirata T, Imamura M, Aikata H, Tanimine N, Kuroda S, Tahara H, Ide K, Ohdan H. Adoptive immunotherapy with natural killer cells from peripheral blood CD34+ stem cells to prevent hepatocellular carcinoma recurrence after curative hepatectomy: a study protocol for an open-label, single-arm phase I study. BMJ Open. 2022 Nov 21;12(11):e064526. doi: 10.1136/bmjopen-2022-064526. |
| 36. |
Sugita J, Atsuta Y, Nakamae H, Maruyama Y, Ishiyama K, Shiratori S, Fukuda T, Kurata M, Shingai N, Ozawa Y, Masuko M, Nagafuji K, Uchida N, Tanaka M, Onizuka M, Kanda J, Kimura T, Ichinohe T, Teshima T. Comparable survival outcomes with haploidentical stem cell transplantation and cord blood transplantation. Bone Marrow Transplant. 2022 Nov;57(11):1681-1688. doi: 10.1038/s41409-022-01770-y. Epub 2022 Aug 20. |
| 37. |
Harada K, Najima Y, Kato M, Fuji S, Shinohara A, Nakamae H, Toyosaki M, Ashiarai M, Onizuka M, Hashii Y, Ichinohe T, Atsuta Y, Nakasone H. Outcomes of salvage haploidentical transplantation using posttransplant cyclophosphamide for graft failure following allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2022 Nov;116(5):744-753. doi: 10.1007/s12185-022-03405-w. Epub 2022 Jun 29. |
| 38. |
Edahiro T, Ureshino H, Chishaki R, Fujino K, Mino T, Yoshida T, Fukushima N, Ichinohe T. Successful combination treatment with azacitidine and venetoclax for a patient with acute myeloid leukemia undergoing hemodialysis. Leuk Lymphoma. 2022 Dec; 63(14):3511-3512. doi: 10.1080/10428194.2022.2123230. EPub 2022 Sep 13. |
| 39. |
Edahiro T, Fukushima N, Otani T, Nakamori M, Nakamichi K, Chishaki R, Fujino K, Mino T, Yoshida T, Sugihara S, Nishizawa M, Ichinohe T. Progressive Multifocal Leukoencephalopathy in Relapsed Ph+ Acute Lymphoblastic Leukemia after Cord Blood Transplantation and Blinatumomab Treatment: A Case Report and Literature Review. Acta Haematol. 2022;145(6):655-661. doi: 10.1159/000526132. Epub 2022 Jul 27. |
| 40. |
Sakatoku K, Kim SW, Okamura H, Kanaya M, Kato K, Yamasaki S, Uchida N, Kobayashi H, Fukuda T, Takayama N, Ishikawa J, Nakazawa H, Sakurai M, Ikeda T, Kondo T, Yoshioka S, Miyamoto T, Kimura T, Ichinohe T, Atsuta Y, Kondo E. Improved survival after single-unit cord blood transplantation using fludarabine and melphalan-based reduced-intensity conditioning for malignant lymphoma: impact of melphalan dose and graft-versus-host disease prophylaxis with mycophenolate mofetil. Ann Hematol. 2022 Dec;101(12):2743-2757. doi: 10.1007/s00277-022-04990-w. Epub 2022 Oct 5. |
| 41. |
Atsuta Y, Sugita J, Nakamae H, Maruyama Y, Ishiyama K, Shiratori S, Fukuda T, Kurata M, Shingai N, Ozawa Y, Masuko M, Nagafuji K, Takada S, Kako S, Kanda Y, Kanda J, Ichinohe T, Teshima T. Comparable survival outcomes with haploidentical stem cell transplantation and unrelated bone marrow transplantation. Bone Marrow Transplant. 2022 Dec;57(12):1781-1787. doi: 10.1038/s41409-022-01822-3. Epub 2022 Sep 12. |
| 42. |
Edahiro T, Ureshino H, Chishaki R, Fujino K, Mino T, Yoshida T, Fukushima N, Ichinohe T. Successful combination treatment with azacitidine and venetoclax as a bridging therapy for third allogenic stem cell transplantation in a patient with 11q23/MLL-rearranged complex karyotype acute myeloid leukemia. EJHaem. 2022 Dec 26;4(1):273-375. https://doi.org/10.1002/ jha2.630. |
| 43. |
Morita-Fujita M, Arai Y, Kondo T, Harada K, Uchida N, Toya T, Ozawa Y, Fukuda T, Ota S, Onizuka M, Kanda Y, Maruyama Y, Takada S, Kawakita T, Ara T, Ichinohe T, Kimura T, Atsuta Y, Kako S. Adult patients with Ph+ ALL benefit from conditioning regimen of medium-dose VP16 plus CY/TBI. Hematol Oncol. 2022 Dec;40(5):1041-1055. doi: 10.1002/hon.3046. Epub 2022 Jul 10. |
| 44. |
Chowdhury S, Fukushima N, Ichinohe T. CAR-T therapy: Blessing of 21st Century. Hiroshima J Med Sci. 2022 Dec;71: 57-66. |
| 45. |
Ureshino H, Kamachi K, Sano H, Okamoto S, Itamura H, Yoshimura M, Katsuya H, Ando T, Kimura S. Higher neutrophil counts are associated with successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia. Hematology. 2022 Dec; 27(1): 1171-1175. doi: 10.1080/16078454.2022.2135857. |
